Posted by: Salvatore J. Zambri, founding partner
The New Jersey Star-Ledger (7/16, Todd) reports that spurred by a “recently published study,” the “Food and Drug Administration is investigating whether some of the most commonly used blood pressure medicines may increase the risks of cancer.”
According to the report, the “agency said it began a review of a class of drugs known as angiotensin receptor blockers after a recently published study suggested the medicines could be associated with a slight increased risk of cancer, according to a notice posted on the FDA’s website.”
The group of drugs under concern include some of the top-selling blood pressure drugs, such as Cozaar, which is manufactured by Merck, and Avapro, a Bristol-Myers Squibb drug.
Before taking any medication, please speak with your doctor, who is obligated to inform you of all risks and benefits of the drug prescribes so you can make the best–most informed–decision about your health.
Do you have any questions about this post?
About the author:
Mr. Zambri is a Board-Certified Civil Trial Attorney and Past-President of the Trial Lawyers Association of Metropolitan Washington, D.C. He has been acknowledged by Washingtonian magazine as a “Big Gun” and among the “top 1%” of all of the more than 80,000 lawyers in the Washington metropolitan area. The magazine also acknowledged him as “one of Washington’s best–most honest and effective lawyers” who specializes in medical malpractice matters, product liability claims, and serious automobile accident claims. Mr. Zambri has also been repeatedly named a “Super Lawyer” by Law and Politics magazine (2010)–a national publication that honors the top lawyers in America.
Mr. Zambri is regularly asked to present seminars to lawyers and doctors, as well as both medical and law students concerning medication errors, medical malpractice litigation, and safety improvements.
If you have any questions about your legal rights, please email Mr. Zambri at email@example.com or call him at 202-822-1899.